Lenalidomide - PDFSEARCH.IO - Document Search Engine

Lenalidomide
Results: 231

#	Item
41	Microsoft Word - pomalidomide-psddocx Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Medical statistics Lenalidomide Orphan drugs Multiple myeloma Bortezomib Dexamethasone Thalidomide End point of clinical trials Celgene Medicine Health Immunosuppressants
42	5.13 POMALIDOMIDE, capsules, 3 mg and 4 mg, Pomalyst®, Celgene Pty Ltd. Purpose of Application Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Medical statistics Lenalidomide Multiple myeloma Bortezomib Dexamethasone End point of clinical trials Thalidomide Celgene Clinical trial Medicine Health Immunosuppressants
43	Encouraging Data on Astex’s Anti-Cancer Drug AT9283 to be Presented at ASH New Data Suggest a Potential Role for AT9283 in Combination With Lenalidomide and With Docetaxel in the Treatment of Multiple Myeloma and Non-H Add to Reading List Source URL: astx.com Language: English Protein kinase inhibitors Tyrosine kinases Immunosuppressants Lenalidomide Orphan drugs CD135 Multiple myeloma Targeted therapy Aurora inhibitor Biology Chemistry Cell biology
44	Haematology Clinical Trials The Department of Haematology at Flinders Medical Centre has a Clinical Trials Unit for research into the diagnosis, monitoring, and treatment of haematological disorders. This includes both b Add to Reading List Source URL: www.fcic.org.au Language: English - Date: 2014-02-25 19:14:38 Acute leukemia Immunosuppressants Lenalidomide Chronic myelogenous leukemia Acute myeloid leukemia Myelodysplastic syndrome Fludarabine Leukemia Janus kinase inhibitor Medicine Oncology Myeloid leukemia
45	Abst. No. Outcomes of Intermediate or High Risk Myelodysplastic Syndromes (MDS) Patients Post Azacitidine and/or Decitabine Treatment Failures with SGI-110, a Novel Second Generation Hypomethylating Agent (HMA) Add to Reading List Source URL: astx.com Language: English Triazines Orphan drugs Azacitidine lactams Myelodysplastic syndrome Decitabine Hypomethylating agent Lenalidomide Acute myeloid leukemia Medicine Oncology Nucleosides
46	National Chemotherapy Algorithms MULTIPLE MYELOMA SEE MYELOMA – TRANSPLANT ELIGIBLE Add to Reading List Source URL: www.engage.england.nhs.uk Language: English - Date: 2015-03-23 13:59:26 Lenalidomide Bortezomib Dexamethasone Thalidomide Chemotherapy Plasma cell leukemia International Myeloma Working Group Medicine Immunosuppressants Multiple myeloma
47	Hindawi Publishing Corporation Case Reports in Hematology Volume 2014, Article ID[removed], 7 pages http://dx.doi.org[removed][removed]Case Report Add to Reading List Source URL: downloads.hindawi.com Language: English - Date: 2014-11-24 07:38:54 Multiple myeloma Plasmacytoma Plasma cell dyscrasia Monoclonal gammopathy of undetermined significance Plasma cell leukemia Bortezomib Bone marrow examination Paraprotein Lenalidomide Medicine Health Hematologic neoplasms
48	SMC briefing note Scottish Medicines Consortium advice to NHSScotland Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Organofluorides Lenalidomide Raltegravir Gefitinib Integrase inhibitor Antiretroviral drug Multiple myeloma Efavirenz Dexamethasone Chemistry Organic chemistry Medicine
49	Drug Name, form(s), strength(s) and Sponsor TGA Indication Current PBS Listing Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 17:21:09 Pharmacology Immunosuppressants Orphan drugs Clinical research Pharmaceutical Benefits Scheme Pharmaceuticals policy Lenalidomide Multiple myeloma Bortezomib Medicine Chemistry Health
50	The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 79th meeting on 3–4 October[removed]DUSC is a national focus of excellence in collecting, analysing and interpre Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:20:02 Healthcare in Australia Immunosuppressants Aging-associated diseases Piperazines Pyrimidines Pharmaceutical Benefits Scheme Quality use of medicines Osteoporosis Lenalidomide Medicine Health Chemistry

UPDATE